Characterization of the neoplastic phenotype in the familial atypical multiple-mole melanoma-pancreatic carcinoma syndrome

scientific article published on 01 August 2003

Characterization of the neoplastic phenotype in the familial atypical multiple-mole melanoma-pancreatic carcinoma syndrome is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/CNCR.11562
P698PubMed publication ID12910525

P2093author name stringHenry T Lynch
Teresa A Brentnall
Melissa A Austin
Stephen J Rulyak
P2860cites workIncreased Risk of Pancreatic Cancer in Melanoma-Prone Kindreds withp16INK4MutationsQ57250780
Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion ofp16 (p16-Leiden)Q57948729
Screening for CDKN2A mutations in hereditary melanomaQ73378729
High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma familiesQ74098963
A new susceptibility locus for autosomal dominant pancreatic cancer maps to chromosome 4q32-34Q24613943
Cancer statistics, 2002Q28216788
A cell cycle regulator potentially involved in genesis of many tumor typesQ28251933
Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinomaQ28300339
Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study GroupQ28307042
Familial atypical multiple mole-melanoma (FAMMM) syndrome: segregation analysis.Q33670822
Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposisQ34378109
Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma-pancreatic carcinoma-prone families: the familial atypical mole melanoma-pancreatic carcinoma syndromeQ34520664
Increased risk of cancer in the Peutz-Jeghers syndromeQ34690977
Inherited pancreatic cancer: surveillance and treatment strategies for affected familiesQ34743083
CDKN2A gene deletions and loss of p16 expression occur in osteosarcomas that lack RB alterationsQ35753196
Pancreatic carcinoma and hereditary nonpolyposis colorectal cancer: a family studyQ35992339
Risk factors for the development of pancreatic cancer in familial pancreatic cancer kindredsQ43409626
Germline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patientsQ44314670
CDKN2A germline mutations in familial pancreatic cancerQ44761150
The Risk of Cancer among Patients with Cystic FibrosisQ56779992
Genotype-Phenotype Relationships in U.S. Melanoma-Prone Families With CDKN2A and CDK4 MutationsQ57250736
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectphenotypeQ104053
P304page(s)798-804
P577publication date2003-08-01
P1433published inCancerQ326041
P1476titleCharacterization of the neoplastic phenotype in the familial atypical multiple-mole melanoma-pancreatic carcinoma syndrome
P478volume98

Reverse relations

cites work (P2860)
Q53518668A family history of pancreatic cancer.
Q35761693Clinical germline genetic testing for melanoma.
Q44828378Effect of a detailed family history of melanoma on risk for other tumors: a cohort study based on the nationwide Swedish Family-Cancer Database
Q61804952Familial Melanoma: Diagnostic and Management Implications
Q38393052Familial atypical multiple mole melanoma syndrome in an adult Indian male-case report and literature review
Q38613449Germline variation at CDKN2A and associations with nevus phenotypes among members of melanoma families.
Q36599686Hereditary melanoma: Update on syndromes and management: Genetics of familial atypical multiple mole melanoma syndrome
Q37211362Malignant melanoma in the 21st century: the emerging molecular landscape
Q36233596Management strategies for patients with hereditary pancreatic cancer
Q37641784Molecular markers of tumor progression in melanoma
Q83001745Novel presentation of a familial pancreatic cancer syndrome
Q34986178Novel targeted therapies for the treatment of metastatic melanoma
Q43581873Prevalence of BRCA2 and CDKN2a mutations in German familial pancreatic cancer families
Q33916380Risk factors for pancreatic adenocarcinoma and prospects for screening.
Q35840024Selection criteria for genetic assessment of patients with familial melanoma
Q81529058[Prophylactic pancreas surgery]